Ambu A/S
OTC:AMBFF

Watchlist Manager
Ambu A/S Logo
Ambu A/S
OTC:AMBFF
Watchlist
Price: 12.75 USD -6.93% Market Closed
Market Cap: 3.4B USD

AMBFF's latest stock split occurred on Jan 3, 2018

The company executed a 5-for-1 stock split, meaning that for every share held, investors received 5 new shares.

Before the split, AMBFF traded at 89.0782 per share. Afterward, the share price was about 21.6526.

The adjusted shares began trading on Jan 3, 2018. This was AMBFF's 2nd stock split, following the previous one in Dec 23, 2014.

Last Splits:
Jan 3, 2018
5-for-1
Dec 23, 2014
4-for-1
Pre-Split Price
17.5529 89.0782
Post-Split Price
21.6526
Before
After
Last Splits:
Jan 3, 2018
5-for-1
Dec 23, 2014
4-for-1

Ambu A/S
Stock Splits History

AMBFF Stock Splits Timeline
Jan 3, 2018
Jan 3, 2018
Split 5-for-1
x5
Pre-Split Price
17.5529 89.0782
Post-Split Price
21.6526
Before
After
Dec 23, 2014
Dec 23, 2014
Split 4-for-1
x4
Pre-Split Price
N/A
Post-Split Price
8.6417
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Jan 20, 2026
Linius Technologies Ltd
OTC:LNNTF
1-for-100
/100
0.0001 0.0001 USD N/A
Jan 20, 2026
Lotus Resources Ltd
OTC:LTSRF
1-for-11
/11
0.1377 0.1377 USD N/A
Jan 15, 2026
Amcor PLC
NYSE:AMCR
1-for-5
/5
8.57 8.57 USD N/A
Jan 8, 2026
Sumitomo Realty & Development Co Ltd
OTC:SURYY
2-for-1
x2
25.635 25.635 USD N/A
Jan 7, 2026
Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG
SWB:EFF
1-for-10
/10
0.35 0.35 EUR N/A
Load More

Ambu A/S
Glance View

Market Cap
3.4B USD
Industry
Health Care

Ambu A/S, a Danish company rooted in innovation, has carved a niche in the global healthcare sector through its specialized medical devices. Founded in 1937, Ambu started with a simple mission of improving patient care and has stayed true to that vision by continuously advancing their portfolio. The company's journey began with the invention of the resuscitator bag, a revolutionary product that remains a staple in emergency and hospital settings today. Over the years, Ambu has focused strategically on three main segments: Anesthesia, Patient Monitoring & Diagnostics, and Visualisation, each playing a crucial role in the broader healthcare ecosystem. These segments allow Ambu to develop devices that enhance diagnostic procedures, improve safety, and increase efficiency in medical settings, ultimately saving lives and optimizing healthcare delivery. Ambu’s business model capitalizes primarily on innovation-driven sales, with a strong emphasis on disposable medical devices which are gaining popularity due to hygiene concerns and regulatory trends favoring single-use technologies. These products include their flagship single-use endoscopes, marketed under the brand name "Ambu aScope," which significantly reduce the risk of cross-contamination while providing high-quality diagnostic images. The company's revenue model is built on a B2B approach, dealing directly with hospitals, clinics, and other healthcare providers, ensuring a steady flow of sales through long-term contracts and partnerships. Through constant reinvestment into R&D and strategic acquisitions, Ambu sustains its market leadership, driving growth by addressing the evolving needs of the healthcare industry and setting standards in patient care solutions globally.

AMBFF Intrinsic Value
16.48 USD
Undervaluation 23%
Intrinsic Value
Price
Back to Top